Shibata T, Ishii T, Tomo T, Kaneko K, Nasu M, Magari Y, Fukushima K
Second Department of Internal Medicine, Medical College of Oita, Japan.
Nihon Jinzo Gakkai Shi. 1991 Apr;33(4):373-8.
In order to clarify the abnormalities of blood coagulation and fibrinolysis in patients with various renal diseases, some molecular markers for hemostasis and thrombosis were examined in comparison with those of the patients with disseminated intravascular coagulation. The results were as follows: 1) PIC was significantly higher in the patients with CGN, NS, SLE, HD and DIC than normal subjects. 2) TAT was significantly higher in the patients with CGN, NS, HD and DIC. 3) SFMC was significantly higher only in the patients of DIC. 4) FDP and FDP-E were significantly higher in the patients with HD and DIC. 5) D-dimer was significantly higher in the patients with CGN, CRF, HD and DIC. These results suggested that the abnormalities of blood coagulation and fibrinolysis in patients with various renal diseases are relatively mild, and situated between the normal subjects and patients with DIC.
为了阐明各种肾脏疾病患者凝血和纤溶异常情况,对一些止血和血栓形成的分子标志物进行了检测,并与弥散性血管内凝血患者的标志物进行比较。结果如下:1)慢性肾小球肾炎(CGN)、肾病综合征(NS)、系统性红斑狼疮(SLE)、血液透析(HD)及弥散性血管内凝血(DIC)患者的纤溶酶-α2纤溶酶抑制物复合物(PIC)显著高于正常受试者。2)CGN、NS、HD及DIC患者的凝血酶-抗凝血酶复合物(TAT)显著升高。3)仅DIC患者的可溶性纤维蛋白单体复合物(SFMC)显著升高。4)HD及DIC患者的纤维蛋白降解产物(FDP)和纤维蛋白原降解产物E(FDP-E)显著升高。5)CGN、慢性肾衰竭(CRF)、HD及DIC患者的D-二聚体显著升高。这些结果表明,各种肾脏疾病患者的凝血和纤溶异常相对较轻,介于正常受试者和DIC患者之间。